Karen J. Ferrante
2015
In 2015, Karen J. Ferrante earned a total compensation of $866.9K as Chief Medical Officer at Tokai Pharmaceuticals, a 46% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $93,100 |
|---|---|
| Option Awards | $393,454 |
| Salary | $380,000 |
| Other | $335 |
| Total | $866,889 |
Ferrante received $393.5K in option awards, accounting for 45% of the total pay in 2015.
Ferrante also received $93.1K in non-equity incentive plan, $380K in salary and $335 in other compensation.
Rankings
In 2015, Karen J. Ferrante's compensation ranked 8,626th out of 13,638 executives tracked by ExecPay. In other words, Ferrante earned more than 36.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,626 out of 13,638 | 37th |
Division Manufacturing | 3,295 out of 5,187 | 37th |
Major group Chemicals And Allied Products | 1,200 out of 1,857 | 35th |
Industry group Drugs | 976 out of 1,531 | 36th |
Industry Pharmaceutical Preparations | 762 out of 1,179 | 35th |
Source: SEC filing on April 29, 2016.
Ferrante's colleagues
We found four more compensation records of executives who worked with Karen J. Ferrante at Tokai Pharmaceuticals in 2015.